MedTrace Logo

Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease.

NCT05146583 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-12-21

No results posted yet for this study

Summary

Lumbar discectomy and injection of purified cellular bone marrow concentrate or lumbar discectomy only

Conditions

  • Lumbar Disc Disease

Interventions

PROCEDURE

Autologous bone marrow aspirate injected intradiscal after microdiscectomy

Harvested from SI-joint, 2-5ml BMA is injected in the discectomy defect.

PROCEDURE

Discectomy only

Transflaval discectomy with or without the use of a microtube (according to surgeons' preference).

Sponsors & Collaborators

  • New York Presbyterian Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-06-01
Completion
2023-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05146583 on ClinicalTrials.gov